AXL is a predictor of poor survival and of resistance to...

European Journal of Cancer 2020 / 10 Vol. 138

AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer

Cardone, Claudia, Blauensteiner, Bernadette, Moreno-Viedma, Veronica, Martini, Giulia, Simeon, Vittorio, Vitiello, Pietro P., Ciardiello, Davide, Belli, Valentina, Matrone, Nunzia, Troiani, Teresa, Mo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
138
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2020.07.010
Date:
October, 2020
File:
PDF, 1.79 MB
2020
Conversion to is in progress
Conversion to is failed